BG Medicine prices initial public offering of 5,000,000 shares of common stock

BG Medicine today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $7.00 per share, before underwriting discounts and commissions. All shares are being sold by the Company. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol "BGMD." In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.

Lazard Capital Markets LLC is acting as the sole bookrunning manager for the initial public offering, and Baird and Cowen and Company are acting as co-managers.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on February 3, 2011. This offering is being made solely by means of a written prospectus, a copy of which may be obtained from Lazard Capital Markets LLC by mail at 30 Rockefeller Plaza, 60th Floor, New York, NY 10020, Attention: Syndicate Department, or by calling toll-free (800) 542-0970.